Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 7
Submit an article Journal homepage
491
Views
12
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapeutic management of co-morbid alcohol and opioid use

Lauren E. HoodDepartment of Psychology, Arizona State University, Tempe, AZ, USAView further author information
,
Jonna M. Leyrer-JacksonDepartment of Psychology, Arizona State University, Tempe, AZ, USAView further author information
&
M. Foster OliveDepartment of Psychology, Arizona State University, Tempe, AZ, USACorrespondence[email protected]
View further author information
Pages 823-839 | Received 21 Aug 2019, Accepted 17 Feb 2020, Published online: 27 Feb 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jonna M. Leyrer-Jackson, Amanda M. Acuña & M. Foster Olive. (2022) Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update. Expert Opinion on Pharmacotherapy 23:16, pages 1819-1830.
Read now

Articles from other publishers (11)

Michelle Colvard. (2023) Concurrent opioid and alcohol withdrawal management. Mental Health Clinician 13:6, pages 268-275.
Crossref
Claire L. Pince, Kimberly E. Whiting, Tammy Wang, András H. Lékó, Lisa A. Farinelli, Diane Cooper, Mehdi Farokhnia, Leandro F. Vendruscolo & Lorenzo Leggio. (2023) Role of aldosterone and mineralocorticoid receptor (MR) in addiction: A scoping review. Neuroscience & Biobehavioral Reviews 154, pages 105427.
Crossref
Ethan Forsgren, Athreya Steiger, Yesenia Perez, David Salazar, Maureen McCollough & Breena R. Taira. (2023) Patient perspectives on emergency department initiation of medication for alcohol use disorder. Academic Emergency Medicine.
Crossref
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, Abhisheak Sharma, Lance R. McMahon & Christopher R. McCurdy. (2023) Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders. Current Addiction Reports 10:2, pages 304-316.
Crossref
Jill A. Rabinowitz, Jin Jin, Sally I-Chun Kuo, Adrian I. Campos, Miguel E. Rentería, Andrew S. Huhn, Johannes Thrul, Beth A. Reboussin, Kelly Benke, Benjamin Domingue, Nicholas S. Ialongo, Brion S. Maher, Darlene Kertes, Vanessa Troiani & George Uhl. (2022) Positive associations between cannabis and alcohol use polygenic risk scores and phenotypic opioid misuse among African-Americans. PLOS ONE 17:4, pages e0266384.
Crossref
John D. Roache, Martina Pavlicova, Aimee Campbell, Tse‐Hwei Choo, Michelle Peavy, Andrea S. Kermack, Edward V. NunesJrJr & John Rotrosen. (2021) Is extended release naltrexone superior to buprenorphine‐naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcoholism: Clinical and Experimental Research 45:12, pages 2569-2578.
Crossref
Monique M. Cherrier, Danny D. Shen, Laura Shireman, Andrew J. Saxon, Tracy Simpson, Alex Men, Preetma Kooner & Gregory W. Terman. (2021) Elevated customary alcohol consumption attenuates opioid effects. Pharmacology Biochemistry and Behavior 211, pages 173295.
Crossref
Kavinash Loganathan, Jinglei Lv, Vanessa Cropley, Andrew Zalesky & Eric Tatt Wei Ho. (2021) Valuation system connectivity is correlated with poly-drug use in young adults. Neuroscience Research 173, pages 114-120.
Crossref
Michael D Smith, Trent Emerick, Scott Brancolini & Benedict Alter. (2021) Clearing up the Confusion: What to Do with Ethanol and Ethanol Metabolites in Urine Drug Screens. Pain Medicine 22:10, pages 2401-2413.
Crossref
Michael T. McCoy, Subramaniam Jayanthi & Jean Lud Cadet. (2021) Potassium Channels and Their Potential Roles in Substance Use Disorders. International Journal of Molecular Sciences 22:3, pages 1249.
Crossref
M. Adrienne McGinn, Caroline B. Pantazis, Brendan J. Tunstall, Renata C.N. Marchette, Erika R. Carlson, Nadia Said, George F. Koob & Leandro F. Vendruscolo. 2021. Neurobiology of Addiction and Co-Morbid Disorders. Neurobiology of Addiction and Co-Morbid Disorders 409 472 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.